(ELIS) Elis - Ratings and Ratios
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0012435121
ELIS EPS (Earnings per Share)
ELIS Revenue
ELIS: Flat Linen, Workwear, Beverage Solutions, Floor Mats, Hygiene Services
Elis SA is a global provider of textile rental and hygiene services, catering to a diverse range of industries, including hospitality, healthcare, and manufacturing. With a presence in multiple regions, the company offers a comprehensive suite of services, from linen rental and laundry management to workwear and personal protective equipment. Its extensive product portfolio includes table linens, workwear, and hygiene solutions, as well as specialized services such as pest control and disinfection.
Operating in over 30 countries, Elis SA has established itself as a leading player in the industry, serving a broad customer base that includes hotels, hospitals, and industrial clients. The companys long history, dating back to 1883, has allowed it to develop a strong expertise in textile management and hygiene services, with a focus on delivering high-quality solutions that meet the evolving needs of its customers.
From a technical analysis perspective, Elis SAs stock has shown a steady upward trend, with its 20-day simple moving average (SMA) at €23.17, above its 50-day SMA of €21.88. The stocks average true range (ATR) is €0.46, indicating a relatively stable price movement. Given the current price of €23.52, and considering the companys strong fundamentals, including a market capitalization of €5.535 billion and a forward P/E ratio of 11.21, we can forecast a potential price target of €25.50 in the next 6-12 months, driven by the companys continued expansion and improving profitability.
Based on the fundamental data, Elis SAs return on equity (RoE) stands at 17.39%, indicating a strong ability to generate profits from shareholder equity. With a P/E ratio of 17.41, the companys shares are reasonably valued compared to its earnings. As the company continues to grow its global presence and expand its services, we expect its earnings to improve, driving the stock price higher. Our forecast is further supported by the companys history of delivering stable returns and its commitment to providing high-quality services to its customers.
Additional Sources for ELIS Stock
ELIS Stock Overview
Market Cap in USD | 6,383m |
Sector | Industrials |
Industry | Specialty Business Services |
GiC Sub-Industry | Diversified Support Services |
IPO / Inception |
ELIS Stock Ratings
Growth Rating | 73.0 |
Fundamental | 66.4 |
Dividend Rating | 53.8 |
Rel. Strength | -5.74 |
Analysts | - |
Fair Price Momentum | 25.32 EUR |
Fair Price DCF | 91.51 EUR |
ELIS Dividends
Dividend Yield 12m | 2.05% |
Yield on Cost 5y | 4.60% |
Annual Growth 5y | 5.14% |
Payout Consistency | 72.3% |
Payout Ratio | 31.9% |
ELIS Growth Ratios
Growth Correlation 3m | 91.1% |
Growth Correlation 12m | 35.2% |
Growth Correlation 5y | 86.4% |
CAGR 5y | 18.93% |
CAGR/Max DD 5y | 0.50 |
Sharpe Ratio 12m | 0.21 |
Alpha | 7.82 |
Beta | 0.601 |
Volatility | 23.91% |
Current Volume | 381.9k |
Average Volume 20d | 338.8k |
As of June 25, 2025, the stock is trading at EUR 23.68 with a total of 381,875 shares traded.
Over the past week, the price has changed by +0.34%, over one month by -1.33%, over three months by +12.19% and over the past year by +12.71%.
Yes, based on ValueRay´s Fundamental Analyses, Elis (PA:ELIS) is currently (June 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 66.35 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ELIS is around 25.32 EUR . This means that ELIS is currently overvalued and has a potential downside of 6.93%.
Elis has no consensus analysts rating.
According to our own proprietary Forecast Model, ELIS Elis will be worth about 27.5 in June 2026. The stock is currently trading at 23.68. This means that the stock has a potential upside of +16.22%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 27.2 | 14.7% |
Analysts Target Price | - | - |
ValueRay Target Price | 27.5 | 16.2% |